CD20 antibodies in the targeting of B-Cell malignancies and autoimmunity (Record no. 78008)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01862ngm a2200373 a 4500 |
001 - CONTROL NUMBER | |
control field | HST1359_1_3 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | UkLoHST |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m c |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr|cna|||a|||| |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | vz|czazum |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 080121s2007 enk|||||||||||s|||v|eng d |
028 50 - PUBLISHER NUMBER | |
Publisher number | 1359 |
Source | Henry Stewart Talks |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (UkLoHST)586 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (UkLU-K)AC000391069 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | UkLU-K |
Language of cataloging | eng |
Transcribing agency | UkLU-K |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Tedder, Thomas F. |
Relator code | spk |
245 10 - TITLE STATEMENT | |
Title | CD20 antibodies in the targeting of B-Cell malignancies and autoimmunity |
Medium | [electronic resource] : |
Remainder of title | mechanisms of B-cell depletion / |
Statement of responsibility, etc. | Thomas F. Tedder. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc. | London : |
Name of publisher, distributor, etc. | Henry Stewart Talks, |
Date of publication, distribution, etc. | 2007. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (1 streaming video file (55 min.) : |
Other physical details | color, sound). |
490 1# - SERIES STATEMENT | |
Series statement | Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, |
International Standard Serial Number | 2056-452X |
500 ## - GENERAL NOTE | |
General note | Animated audio-visual presentation with synchronized narration. |
500 ## - GENERAL NOTE | |
General note | Title from title frames. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Contents: Antibody targeting of B-cell malignancies and autoimmunity -- CD20 antibody immunotherapy -- CD20 structure and function -- Antibody-dependent cellular cytotoxicity -- Complement-dependent cytotoxicity -- Mouse models of CD20 immunotherapy -- Lymphoma immunotherapy -- Immunotherapy for autoimmunity. |
506 ## - RESTRICTIONS ON ACCESS NOTE | |
Terms governing access | Access restricted to subscribers. |
538 ## - SYSTEM DETAILS NOTE | |
System details note | Mode of access: World Wide Web. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Antibodies, Monoclonal |
General subdivision | therapeutic use. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Antigens, CD20. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Autoimmunity. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | B-Lymphocytes. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Immunotherapy. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Henry Stewart talks. |
Name of part/section of a work | Biomedical & life sciences collection. |
-- | Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://hstalks.com/bs/586/">https://hstalks.com/bs/586/</a> |
856 42 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://hstalks.com/bs/p/30/">https://hstalks.com/bs/p/30/</a> |
Materials specified | Series |
No items available.